55
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      m 6A RNA methylation promotes XIST-mediated transcriptional repression

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The long non-coding RNA X-inactive specific transcript ( XIST) mediates the transcriptional silencing of genes on the X chromosome. Here we show that in human cells XIST is highly methylated with at least 78 N 6-methyladenosine (m 6A) residues—a reversible base modification of unknown function in long non-coding RNAs. We show that m 6A formation in XIST, as well as in cellular mRNAs, is mediated by RNA binding motif protein 15 (RBM15) and its paralogue RBM15B, which bind the m 6A-methylation complex and recruit it to specific sites in RNA. This results in the methylation of adenosine nucleotides in adjacent m 6A consensus motifs. Furthermore, we show that knockdown of RBM15 and RBM15B, or knockdown of methyltransferase like 3 ( METTL3), an m 6A methyltransferase, impairs XIST-mediated gene silencing. A systematic comparison of m 6A-binding proteins shows that YTH domain containing 1 (YTHDC1) preferentially recognizes m 6A residues on XIST and is required for XIST function. Additionally, artificial tethering of YTHDC1 to XIST rescues XIST-mediated silencing upon loss of m 6A. These data reveal a pathway of m 6A formation and recognition required for XIST-mediated transcriptional repression.

          Related collections

          Most cited references19

          • Record: found
          • Abstract: found
          • Article: not found

          The Xist lncRNA exploits three-dimensional genome architecture to spread across the X chromosome.

          Many large noncoding RNAs (lncRNAs) regulate chromatin, but the mechanisms by which they localize to genomic targets remain unexplored. We investigated the localization mechanisms of the Xist lncRNA during X-chromosome inactivation (XCI), a paradigm of lncRNA-mediated chromatin regulation. During the maintenance of XCI, Xist binds broadly across the X chromosome. During initiation of XCI, Xist initially transfers to distal regions across the X chromosome that are not defined by specific sequences. Instead, Xist identifies these regions by exploiting the three-dimensional conformation of the X chromosome. Xist requires its silencing domain to spread across actively transcribed regions and thereby access the entire chromosome. These findings suggest a model in which Xist coats the X chromosome by searching in three dimensions, modifying chromosome structure, and spreading to newly accessible locations.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            MTA is an Arabidopsis messenger RNA adenosine methylase and interacts with a homolog of a sex-specific splicing factor.

            N6-Methyladenosine is a ubiquitous modification identified in the mRNA of numerous eukaryotes, where it is present within both coding and noncoding regions. However, this base modification does not alter the coding capacity, and its biological significance remains unclear. We show that Arabidopsis thaliana mRNA contains N6-methyladenosine at levels similar to those previously reported for animal cells. We further show that inactivation of the Arabidopsis ortholog of the yeast and human mRNA adenosine methylase (MTA) results in failure of the developing embryo to progress past the globular stage. We also demonstrate that the arrested seeds are deficient in mRNAs containing N6-methyladenosine. Expression of MTA is strongly associated with dividing tissues, particularly reproductive organs, shoot meristems, and emerging lateral roots. Finally, we show that MTA interacts in vitro and in vivo with At FIP37, a homolog of the Drosophila protein FEMALE LETHAL2D and of human WILMS' TUMOUR1-ASSOCIATING PROTEIN. The results reported here provide direct evidence for an essential function for N6-methyladenosine in a multicellular eukaryote, and the interaction with At FIP37 suggests possible RNA processing events that might be regulated or altered by this base modification.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              The RNA-binding protein repertoire of embryonic stem cells.

              RNA-binding proteins (RBPs) have essential roles in RNA-mediated gene regulation, and yet annotation of RBPs is limited mainly to those with known RNA-binding domains. To systematically identify the RBPs of embryonic stem cells (ESCs), we here employ interactome capture, which combines UV cross-linking of RBP to RNA in living cells, oligo(dT) capture and MS. From mouse ESCs (mESCs), we have defined 555 proteins constituting the mESC mRNA interactome, including 283 proteins not previously annotated as RBPs. Of these, 68 new RBP candidates are highly expressed in ESCs compared to differentiated cells, implicating a role in stem-cell physiology. Two well-known E3 ubiquitin ligases, Trim25 (also called Efp) and Trim71 (also called Lin41), are validated as RBPs, revealing a potential link between RNA biology and protein-modification pathways. Our study confirms and expands the atlas of RBPs, providing a useful resource for the study of the RNA-RBP network in stem cells.
                Bookmark

                Author and article information

                Journal
                0410462
                6011
                Nature
                Nature
                Nature
                0028-0836
                1476-4687
                29 April 2017
                07 September 2016
                15 September 2016
                13 July 2017
                : 537
                : 7620
                : 369-373
                Affiliations
                [1 ]Department of Pharmacology, Weill-Cornell Medical College, Cornell University, New York, New York 10065, USA
                [2 ]Division of Biology and Biological Engineering, California Institute of Technology, Pasadena, California 91125, USA
                Author notes
                Correspondence and requests for materials should be addressed to S.R.J. ( srj2003@ 123456med.cornell.edu )
                Article
                PMC5509218 PMC5509218 5509218 nihpa870841
                10.1038/nature19342
                5509218
                27602518
                d6ca135d-5ccb-4f05-a13b-63b74fb4ac59

                Reprints and permissions information is available at www.nature.com/reprints.

                History
                Categories
                Article

                Comments

                Comment on this article